XML 51 R29.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Description of Business (Tables) | 2 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 31, 2014 | Dec. 31, 2014 | Jan. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract] |  |  |
Summary of Condensed Consolidated Balance Sheet | Condensed Consolidated Balance Sheets
|  | As of March 31, 2014 |  | As of January 31, 2014 |
|  | As Reported |  | As Restated |  | As Reported |  | As Restated |
Prepaid consulting |  | $ | - |  | $ | - |  | $ | (282,176) |  | $ | - |
Additional paid-in-capital |  | $ | 15,127,587 |  | $ | 15,127,587 |  | $ | 14,429,810 |  | $ | 14,147,634 |
Accumulated deficit |  | $ | (16,347,588) |  | $ | (17,537,920) |  | $ | (15,581,146) |  | $ | (16,771,478) |
Stockholders' Deficit Attributable to Apollo Medical Holdings, Inc. |  | $ | (408,067) |  | $ | (2,405,420) |  | $ | (1,428,817) |  | $ | (2,619,149) |
Non-controlling interest |  | $ | (1,623,155) |  | $ | 782,265 |  | $ | (263,901) |  | $ | 926,431 |
Condensed Consolidated Balance Sheets |  |  |  |  |  |  |  |  |  |  |  |  |
|  | As of December 31, 2014 |  | As of March 31, 2014 |
|  | As Reported |  | As Restated |  | As Reported |  | As Restated |
Accumulated deficit |  | $ | (18,340,602) |  | $ | (19,530,934) |  | $ | (16,347,588) |  | $ | (17,537,920) |
Stockholders' Deficit Attributable to Apollo Medical Holdings, Inc. |  | $ | (1,953,892) |  | $ | (3,144,224) |  | $ | (1,215,088) |  | $ | (2,405,420) |
Non-controlling interest |  | $ | 482,151 |  | $ | 1,672,483 |  | $ | (408,067) |  | $ | 782,265 |
| The impact of the correction of these errors to our previously reported fiscal year ended January 31, 2014 and 2013 annual periods is summarized below. Consolidated Balance Sheets
|  | As of January 31, 2014 |  | As of January 31, 2013 |
|  | As Reported |  | As Restated |  | As Reported |  | As Restated |
Prepaid consulting |  | $ | (282,176) |  | $ | - |  | $ | (616,014) |  | $ | - |
Additional paid-in-capital |  | $ | 14,429,810 |  | $ | 14,147,634 |  | $ | 11,279,926 |  | $ | 10,663,912 |
Accumulated deficit |  | $ | (15,581,146) |  | $ | (16,771,478) |  | $ | (11,022,272) |  | $ | (11,751,180) |
Total stockholders’ deficit attributable to Apollo Medical Holdings, Inc. |  | $ | (1,428,817) |  | $ | (2,619,149) |  | $ | (354,876) |  | $ | (1,083,784) |
Non-controlling interest |  | $ | (1,692,718) |  | $ | 926,431 |  | $ | (391,379) |  | $ | 692,405 |
Condensed Income Statement | Condensed Consolidated Statements of Operations for Two Months Ended
|  | March 31, 2013 |
|  | As Reported |  | As Restated |
Net income attributable to noncontrolling interest |  | $ | - |  | $ | (79,296) |
Net loss attributable to Apollo Medical Holdings, Inc. |  | $ | (145,103) |  | $ | (224,399) |
Basic and diluted net loss per share |  | $ | - |  | $ | (0.06) |
Condensed Consolidated Statements of Operations for Three Months Ended |  |  |  |  |  |  |
|  | December 31, 2013 |
|  | As Reported |  | As Restated |
Net income attributable to noncontrolling interest |  | $ | - |  | $ | 110,040 |
Net loss attributable to Apollo Medical Holdings, Inc. |  | $ | (964,792) |  | $ | (1,074,832) |
Basic and diluted net income (loss) per share |  | $ | (0.25) |  | $ | (0.28) |
Condensed Consolidated Statements of Operations for Nine Months Ended |  |  |  |  |  |  |
|  | December 31, 2013 |
|  | As Reported |  | As Restated |
Net income attributable to noncontrolling interest |  | $ | - |  | $ | 339,368 |
Net loss attributable to Apollo Medical Holdings, Inc. |  | $ | (3,878,392) |  | $ | (4,217,760) |
Basic and diluted net loss per share |  | $ | (1.04) |  | $ | (1.13) |
| Consolidated Statements of Operations for Year Ended
|  | January 31, 2014 |  | January 31, 2013 |
|  | As Reported |  | As Restated |  | As Reported |  | As Restated |
Net income attributable to noncontrolling interest |  | $ | - |  | $ | (461,424) |  | $ | - |  | $ | (501,501) |
Net loss attributable to Apollo Medical Holdings, Inc. |  | $ | (4,558,874) |  | $ | (5,020,298) |  | $ | (8,904,564) |  | $ | (9,406,065) |
Basic and diluted net loss per share |  | $ | (1.24) |  | $ | (1.37) |  | $ | (2.74) |  | $ | (2.90) |

X
- Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration